Artículos de revistas sobre el tema "Gcb-Dlbcl"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Gcb-Dlbcl".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Pukiat, Sulada, Nuttapong Ngamphaiboon, Pooja Advani, Julio Chavez, George Deeb, Anjana Elefante y Francisco J. Hernandez-Ilizaliturri. "BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy". Blood 116, n.º 21 (19 de noviembre de 2010): 3130. http://dx.doi.org/10.1182/blood.v116.21.3130.3130.
Texto completoTarius, Jenifer Marsela, Hermawan Istiadi, Ika Pawitra Miranti y Intan Rahmania Eka Dini. "THE CORRELATION BETWEEN CELL OF ORIGIN SUBTYPE WITH OVERALL SURVIVAL OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN KARIADI GENERAL HOSPITAL SEMARANG". DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO) 9, n.º 3 (12 de mayo de 2020): 252–58. http://dx.doi.org/10.14710/dmj.v9i3.27504.
Texto completoGandhi, Shipra, Vishala T. Neppalli, George Deeb, Myron S. Czuczman y Francisco J. Hernandez-Ilizaliturri. "Distinct CD30 Expression Patterns In Germinal Center B-Cell (GCB) and Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL)". Blood 122, n.º 21 (15 de noviembre de 2013): 5064. http://dx.doi.org/10.1182/blood.v122.21.5064.5064.
Texto completoHayama, Miyuki, Masataka Okamoto, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Tadashi Yoshino, Koichi Ohshima y Nozomi Niitsu. "Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era." Blood 116, n.º 21 (19 de noviembre de 2010): 1800. http://dx.doi.org/10.1182/blood.v116.21.1800.1800.
Texto completoKharchenko, Yevgeniya, Tatyana Semiglazova, Anna Artemeva, Galina Kireeva, I. Polyatskin, Ilya Zyuzgin, Larisa Filatova, Yuliya Chudinovskikh, Margarita Motalkina y Yuliya Oleynik. "PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA". Problems in oncology 66, n.º 1 (1 de enero de 2020): 79–89. http://dx.doi.org/10.37469/0507-3758-2020-66-1-79-89.
Texto completoAdhi Pangarsa, Eko, Desta Nur Ewika Ardini, Daniel Rizky, Kevin Tandarto, Hermawan Istiadi, Dik Puspasari, Budi Setiawan et al. "The association of Hypoxia-Inducible Factor-2α (HIF-2α) overexpression score with Germinal Center B-Cell Like (GCB) and Non-Germinal Center B-Cell Like (Non-GCB) subtypes of Diffuse Large B-cell Lymphoma (DLBCL)". Bali Medical Journal 12, n.º 3 (22 de agosto de 2023): 2456–62. http://dx.doi.org/10.15562/bmj.v12i3.4521.
Texto completoMishima, Yuko, Masahiro Yokoyama, Noriko Nishimura, Kyoko Ueda, Tadahiro Gunji, Hideaki Nitta, Yoshiharu Kusano et al. "R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL". Blood 126, n.º 23 (3 de diciembre de 2015): 1507. http://dx.doi.org/10.1182/blood.v126.23.1507.1507.
Texto completoChavez, Julio, Mark Walsh, Francisco J. Hernandez-Ilizaliturri, Anjana Elefante y Myron S. Czuczman. "Classification of Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) According to the Han's Criteria Defines Two Groups of Patients with Different Clinical Outcomes Following Systemic Rituximab-Multi Agent Anthracycline-Based Therapy." Blood 114, n.º 22 (20 de noviembre de 2009): 623. http://dx.doi.org/10.1182/blood.v114.22.623.623.
Texto completoVan Meerten, Tom, Renee Bouwstra, Yuan He, de Boer Janneke, Hilde Kooistra, Rudolf Fehrmann, Emanuele Ammatuna, Gerwin Huls y Edwin Bremer. "CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)". Blood 132, Supplement 1 (29 de noviembre de 2018): 2852. http://dx.doi.org/10.1182/blood-2018-99-114561.
Texto completoNiitsu, Nozomi, Naoki Takahashi, Tadashi Yoshino, Masataka Okamoto y Shigeo Nakamura. "Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era". Blood 126, n.º 23 (3 de diciembre de 2015): 3911. http://dx.doi.org/10.1182/blood.v126.23.3911.3911.
Texto completoAlam, SM Mahbubul y Ahmed Khaled. "Immunophenotypic characteristics of Diffuse Large Bcell Lymphoma". Bioresearch Communications 8, n.º 1 (26 de diciembre de 2021): 1049–52. http://dx.doi.org/10.3329/brc.v8i1.57043.
Texto completoNooruddin, Zohra, Zenggang Pan, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, Daniel A. Pollyea, Jonathan A. Gutman et al. "Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes". Blood 128, n.º 22 (2 de diciembre de 2016): 3054. http://dx.doi.org/10.1182/blood.v128.22.3054.3054.
Texto completoSlimani, Yasmine, Fouzia Hali y Fatima-Zohra El Fatoiki. "Triple-negative diffuse large B-cell lymphoma: A distinct entity". Our Dermatology Online 12, n.º 4 (19 de octubre de 2021): 427–29. http://dx.doi.org/10.7241/ourd.20214.17.
Texto completoLossos, Izidore S., XiaoQing Lu, Feiying Ding, Manuel Rosado, Ash A. Alizadeh y Hovav Nechushtan. "Distinct IL-4 Intracellular Signaling in Germinal Center B-Cell like and Activated B-Cell like Diffuse Large B-Cell Lymphoma: Novel Opportunities for Therapeutic Interventions." Blood 104, n.º 11 (16 de noviembre de 2004): 244. http://dx.doi.org/10.1182/blood.v104.11.244.244.
Texto completoCosta, Luciano J., Andrew L. Feldman, Ivana N. Micallef, David J. Inward, Patrick B. Johnston, Luis F. Porrata, Mark R. Litzow y Stephen M. Ansell. "Germinal Center B Cell and Non-Germinal Center B Cell-Like DLBCL Have Similar Clinical Features at the Time of Progression and Comparable Outcome Following Autologous HSC Transplantation." Blood 110, n.º 11 (16 de noviembre de 2007): 1901. http://dx.doi.org/10.1182/blood.v110.11.1901.1901.
Texto completoJulianty, Patricia Fransisca, Maria Francisca Ham, Kusmardi Kusmardi y Agnes Stephanie Harahap. "CD30 Expression in Germinal Center B-cell-like and non-Germinal Center B-cell-like Subtypes of Diffuse Large B-cell Lymphoma". Open Access Macedonian Journal of Medical Sciences 8, B (17 de abril de 2020): 375–80. http://dx.doi.org/10.3889/oamjms.2020.4645.
Texto completoLenz, Georg, George Wright, Sandeep Dave, Alexander Kohlmann, Wenming Xiao, John Powell, Hong Zhao et al. "Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy." Blood 110, n.º 11 (16 de noviembre de 2007): 348. http://dx.doi.org/10.1182/blood.v110.11.348.348.
Texto completoNechushtan, Hovav, Joseph D. Rosenblatt y Izidore S. Lossos. "IL-4 Affects Proliferation, Chemosensitivity-and Rituximab Sensitivity of Germinal Center B-Cell like (GCB) and Activated B-Cell like (ABC) Diffuse Large B-Cell Lymphoma Differently." Blood 104, n.º 11 (16 de noviembre de 2004): 242. http://dx.doi.org/10.1182/blood.v104.11.242.242.
Texto completoLocatelli, Silvia L., Roberto Papait, Giuseppa Careddu, Ada Koschorke, Giuliano G. Stirparo, Monica Balzarotti, Luca Castagna, Armando Santoro y Carmelo Carlo-Stella. "Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL)". Blood 124, n.º 21 (6 de diciembre de 2014): 2253. http://dx.doi.org/10.1182/blood.v124.21.2253.2253.
Texto completoKleinstern, Geffen, Dennis P. Robinson, Lisa M. Rimsza, Melissa C. Larson, Rebecca L. King, Grzegorz S. Nowakowski, Carrie A. Thompson et al. "Abstract 741: Evaluation of etiologic heterogeneity for risk of diffuse large B-cell lymphoma (DLBCL) subtype defined by cell-of-origin". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 741. http://dx.doi.org/10.1158/1538-7445.am2022-741.
Texto completoFu, Kai, Dennis D. Weisenburger, William W. L. Choi, Kyle D. Perry, Lynette M. Smith, Xinlan Shi, Christine P. Hans et al. "Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma". Journal of Clinical Oncology 26, n.º 28 (1 de octubre de 2008): 4587–94. http://dx.doi.org/10.1200/jco.2007.15.9277.
Texto completoCao, Yabing, Ying Huang, Sheng Ye y Tongyu Lin. "Prognostic impact of immunohistochemically defined germinal center B-cell and nongerminal center B-cell subtypes of diffuse large B-cell lymphoma in rituximab era." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e18517-e18517. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18517.
Texto completoHuang, Ying, Sheng Ye, Yabing Cao, Zhiming Li, Jiajia Huang, He Huang, Muyan Cai, Rongzhen Luo y Tongyu Lin. "Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients". Scientific World Journal 2012 (2012): 1–7. http://dx.doi.org/10.1100/2012/897178.
Texto completoDunleavy, Kieron, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin et al. "Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma". Blood 113, n.º 24 (11 de junio de 2009): 6069–76. http://dx.doi.org/10.1182/blood-2009-01-199679.
Texto completoWenzl, Kerstin, Bryce Manso, Yan W. Asmann, Matthew J. Maurer, Michelle Manske, Zhi-Zhang Yang, Susan L. Slager et al. "Whole-Exome Analysis Reveals Novel Somatic Genomic Alterations Associated with Cell of Origin in Diffuse Large B-Cell Lymphoma". Blood 128, n.º 22 (2 de diciembre de 2016): 2935. http://dx.doi.org/10.1182/blood.v128.22.2935.2935.
Texto completoDe Paepe, Pascale, Ruth Achten, Gregor Verhoef, Iwona Wlodarska, Michel Stul, Vera Vanhentenrijk, Marleen Praet y Chris De Wolf-Peeters. "Large Cleaved and Immunoblastic Lymphoma May Represent Two Distinct Clinicopathologic Entities Within the Group of Diffuse Large B-Cell Lymphomas". Journal of Clinical Oncology 23, n.º 28 (1 de octubre de 2005): 7060–68. http://dx.doi.org/10.1200/jco.2005.15.503.
Texto completoDekker, Joseph D., Daechan Park, Arthur L. Shaffer, Holger Kohlhammer, Wei Deng, Bum-Kyu Lee, Gregory C. Ippolito et al. "Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1". Proceedings of the National Academy of Sciences 113, n.º 5 (19 de enero de 2016): E577—E586. http://dx.doi.org/10.1073/pnas.1524677113.
Texto completoWaller, Rosalie Griffin, Dennis P. Robinson, Anne J. Novak, Lisa M. Rimsza, Kerstin Wenzl, Rebecca L. King, Andrew L. Feldman et al. "Abstract 1181: Etiologic heterogeneity of genetic risk for DLBCL cell-of origin molecular subtypes". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1181. http://dx.doi.org/10.1158/1538-7445.am2023-1181.
Texto completoKim, Yu Ri, Soo-Jeong Kim, June-Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Deok-Hwan Yang et al. "Upfront Autologous Stem Cell Transplantation Overcome the poor Prognosis of Non-Germinal Center Subtype of diffuse Large B-Cell Lymphoma in Patients with Advanced Stage and Elevated Serum Lactate Dehydrogenase". Blood 124, n.º 21 (6 de diciembre de 2014): 3998. http://dx.doi.org/10.1182/blood.v124.21.3998.3998.
Texto completoSoo, Joanne, David Matthew Kurtz, Florian Scherer, Alexander F. M. Craig, Michael C. Jin, Jason R. Westin, Davide Rossi et al. "Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 7538. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.7538.
Texto completoXu-Monette, Zijun Y., Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand et al. "Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma". Blood 128, n.º 26 (29 de diciembre de 2016): 3083–100. http://dx.doi.org/10.1182/blood-2016-05-715094.
Texto completoFoureau, David, Lawrence J. Druhan, Nury M. Steuerwald, Sarah A. Baxter, Omotayo O. Fasan, Belinda R. Avalos y Nilanjan Ghosh. "Cytokine Profiling of ABC-Subtype and GCB-Subtype Diffuse Large B Cell Lymphoma: Systemic Nfkb Activation and Impact on Myeloid-Derived Suppressor Cells Distribution". Blood 126, n.º 23 (3 de diciembre de 2015): 2666. http://dx.doi.org/10.1182/blood.v126.23.2666.2666.
Texto completoHavranek, Ondrej, Jingda Xu, Stefan Koehrer, Zhiqiang Wang, Justin M. Comer, Lisa Becker, Allen F. Yi et al. "Molecular Aspects of Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma Provide Biomarkers and Targets for Specific Inhibition". Blood 128, n.º 22 (2 de diciembre de 2016): 779. http://dx.doi.org/10.1182/blood.v128.22.779.779.
Texto completoTakizawa, Jun, Sadao Aoki, Akihito Momoi, Toshiki Kitajima, Masutaka Higashimura, Naoya Nakamura y Yoshifusa Aizawa. "BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma." Blood 108, n.º 11 (16 de noviembre de 2006): 4620. http://dx.doi.org/10.1182/blood.v108.11.4620.4620.
Texto completoGupta, Mamta, Guangzhen Hu, Steven Offer, Matthew J. Maurer, Linda Wellik, Jing Jing Han, Ahmet Dogan, Robert B. Diasio y Thomas E. Witzig. "Expression but Not Promoter Hypermethylation of the Tyrosine Phosphatase PTPN6 Is Associated with Activated STAT3 and Inferior Prognosis in Diffuse Large B Cell Lymphoma Molecular Subtypes." Blood 120, n.º 21 (16 de noviembre de 2012): 2655. http://dx.doi.org/10.1182/blood.v120.21.2655.2655.
Texto completoZhao, Fengyi, Lei Zhang, Yan Qin, Ming-Zhe Han, Xiaohong Han, Shiyu Jiang y Yuankai Shi. "Characterization of Methylation Patterns in Diffuse Large B Cell Lymphoma By Genome-Wide Methylation Analysis". Blood 134, Supplement_1 (13 de noviembre de 2019): 1243. http://dx.doi.org/10.1182/blood-2019-131656.
Texto completoAlcoceba, Miguel, Elena Sebastián, Ana Balanzategui, Luis Marín, Santiago Montes-Moreno, Teresa Flores, Noemí Puig et al. "Preferential Acquision of N-Glycosylation Sites in the VDJ Region in Germinal Center B-Cell-Like Difusse Large B-Cell Lymphoma". Blood 120, n.º 21 (16 de noviembre de 2012): 1589. http://dx.doi.org/10.1182/blood.v120.21.1589.1589.
Texto completoNowakowski, Grzegorz S., Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson et al. "Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study". Journal of Clinical Oncology 33, n.º 3 (20 de enero de 2015): 251–57. http://dx.doi.org/10.1200/jco.2014.55.5714.
Texto completoGozgit, Joseph M., Youngchul Song, Scott Wardwell, Sara Nadworny, Yaoyu Ning y Victor M. Rivera. "Potent Preclinical Activity of Ponatinib in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma (GCB-DLBCL) Models". Blood 126, n.º 23 (3 de diciembre de 2015): 4000. http://dx.doi.org/10.1182/blood.v126.23.4000.4000.
Texto completoZettl, Andreas, Silvia Bea, George Wright, Itziar Salaverria, Philipp Jehn, German Ott, Wing-Chung Chan et al. "Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work)." Blood 104, n.º 11 (16 de noviembre de 2004): 415. http://dx.doi.org/10.1182/blood.v104.11.415.415.
Texto completoCao, Y., T. Lin, S. Wang, X. Fu, J. Xiao, J. Yi, H. Lin y Z. Guan. "A phase II study of R-CHOP in treatment of diffuse large B-cell lymphoma (DLBCL) subgroups". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 17540. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.17540.
Texto completoZhao, Peiqi, Huilai Zhang, Kai Fu, Xianhuo Wang, Lanfang Li, Zhengzi Qian, Lihua Qiu y Shiyong Zhou. "CD5 Expression Correlates with Inferior Survival and Enhances the Negative Effect of p53 Overexpression in Diffuse Large B Cell Lymphoma". Blood 134, Supplement_1 (13 de noviembre de 2019): 4117. http://dx.doi.org/10.1182/blood-2019-127666.
Texto completoWang, Y. Lynn, Jiao Ma, Wei Xing, Pin Lu, Karen Dresser, Ailin Guo, Anjali Pandey, Pamela B. Conley, Hongbo Yu y Greg Coffey. "SYK and STAT3 Are Active in Diffuse Large B-Cell Lymphoma: Activity of Cerdulatinib, a Dual SYK/JAK Inhibitor". Blood 124, n.º 21 (6 de diciembre de 2014): 926. http://dx.doi.org/10.1182/blood.v124.21.926.926.
Texto completoFeng, Ru, Xiaolei Wei, Meng Xu, Fen Huang, Yongqiang Wei, Tong Zhao y B. Hilda Ye. "STAT3 Predicts Poor Outcome In Patients With Advanced Diffuse Large B Cell Lymphoma". Blood 122, n.º 21 (15 de noviembre de 2013): 5069. http://dx.doi.org/10.1182/blood.v122.21.5069.5069.
Texto completoQu, Jie, Matthew J. Maurer, James R. Cerhan, Anne J. Novak, Thomas M. Habermann, William R. Macon, Andrew L. Feldman et al. "Similar Phenotypes Demonstrated upon Initial Diagnosis and at Time of Recurrence in Relapsed DLBCL". Blood 128, n.º 22 (2 de diciembre de 2016): 5299. http://dx.doi.org/10.1182/blood.v128.22.5299.5299.
Texto completoEnnishi, Daisuke, Ali Bashashati, Saeed Saberi, Anja Mottok, Barbara Meissner, Merrill Boyle, Susana Ben-Neriah et al. "Frequent Genetic Alterations of PI3K-AKT Pathway and Their Clinical Significance in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma". Blood 128, n.º 22 (2 de diciembre de 2016): 607. http://dx.doi.org/10.1182/blood.v128.22.607.607.
Texto completoPrakash, Gaurav, Atul Sharma, Vinod Raina, Lalit Kumar y Mehar C. Sharma. "Outcome in different molecular subtypes of diffuse large B-cell lymphoma: Indian experience." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e18518-e18518. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18518.
Texto completoYunalda, Indah, Krisna Murt, Aida Farida, Ika Kartika y Erial Bahar. "Density of CD8 in Tumor Microenvironment of Diffuse Large B Cell Lymphoma Subtypes". Majalah Patologi Indonesia 30, n.º 2 (1 de mayo de 2021): 227–33. http://dx.doi.org/10.55816/mpi.v30i2.466.
Texto completoTatterton, Dylan J., Benjamin Sale, Joel Allen, Maddy L. Newby, Giorgia Chiodin, Patrick J. Duriez, John Butler et al. "Oligomannose-Type Glycans in the Antigen Binding Site Identify Origin and Prognosis of Diffuse Large B Cell Lymphoma". Blood 142, Supplement 1 (28 de noviembre de 2023): 428. http://dx.doi.org/10.1182/blood-2023-188721.
Texto completoFu, K., K. D. Perry, L. M. Smith, C. P. Hans, T. C. Greiner, W. C. Chan, D. D. Weisenburger et al. "Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 8040. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.8040.
Texto completo